Field Notes · November 6, 2025 · 5 min · By Desmond Okafor

Who treats whom in Los Angeles

A look at celebrity dermatology disclosure norms, and what we can ethically report.

A woman in large sunglasses leaving a discreet upscale medical office entrance framed by hedges

Every few weeks a publicist calls a publication like this one offering an exclusive: a named star, a named procedure, a named doctor, photos available. The transaction on offer is older than the tabloids, and it is worth explaining why we decline it, because the explanation doubles as a map of how information about cosmetic dermatology actually moves through this city.

The legal floor. Start with the non-negotiable. Medical privacy law binds the clinic, not the press: a physician who confirms that a particular person is a patient violates federal privacy protections, full stop, while a publication that reports it generally breaks no law. That asymmetry creates the whisper economy. Doctors cannot talk, so the talking is done by adjacent parties, stylists, managers, former staff, and sometimes the patients themselves through intermediaries, each with an agenda the reader never sees.

The disclosure spectrum. Public figures handle the question along a recognizable spectrum. At one end, total denial, increasingly rare because it is increasingly falsifiable. In the middle, the strategic partial: admitting a modest procedure, sunscreen and a little botox, to buy credibility while omitting the rest. At the other end, the new full-disclosure influencer, who names products, doctors, and prices on camera, and who is frequently compensated for exactly that transparency. Each mode is a media strategy. None of them is medical information.

Why the incentives run through doctors too. A celebrity clientele is the most valuable marketing asset a Beverly Hills practice can hold, and the value depends on discretion that is visible. Hence the studied ambiguity of the physician profile that mentions treating well-known faces without naming one. Some practices trade access quietly, offering treatment at reduced rates in exchange for tagged posts or word-of-mouth in the right rooms. The reader scrolling a before-and-after feed cannot distinguish a paid face from a paying one, which is rather the point.

What this publication will and will not do. We do not report which named individuals had which procedures, sourced or unsourced, because the sourcing is unverifiable by design and the private medical choices of individuals are not, in themselves, news. We do report on the system: pricing, safety records, marketing practices, conflicts of interest, and the gap between what is sold and what the evidence supports, the same gap we track across the cosmetic and medical halves of the specialty. When a public figure voluntarily discusses their own treatment on the record, that is fair material, quoted as media, not confirmed as medicine.

Why readers should care about the sourcing rules. Because the whisper economy sets expectations that walk into consultation rooms. Patients arrive asking for the jawline of a person whose actual regimen, surgeon, budget, and lighting rig are all unknown, and clinics quote treatment plans against that fiction. The disclosure norms of 2026, documented in our report on the current Beverly Hills look, make this worse in a specific way: the fashionable result is now invisible work, so the most influential faces are precisely the ones whose work cannot be seen or verified at all.

A practical filter. When you encounter a claim about who did whose face, ask three questions. Who benefits from my believing this? Could the speaker actually know it? And would the claim survive the subject saying it aloud on the record? Almost nothing in the genre survives all three. What survives instead, and what we try to publish, is the boring, useful layer underneath: what procedures cost, what they can and cannot do, and how to judge the person holding the syringe rather than the person in the waiting room before you.

Related reading: The Beverly Hills look, 2026.